Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The US Preventive Services Task Force (USPSTF) has published updated recommendations on screening for syphilis infection in adults and adolescents.
Syphilis is a sexually transmitted infection caused by bacteria called Treponema pallidum. There are different stages of syphilis, and each stage has different symptoms. Primary syphilis occurs 2 or 3 weeks after infection, with symptoms of 1 or more small, painless ulcers (chancres) in areas of sexual contact. Because the chancres are painless and go away on their own, many people do not seek treatment. This can lead to secondary syphilis a few weeks or months later. Symptoms of secondary syphilis include flulike symptoms, fever, a widespread rash, and swollen lymph nodes. If still left untreated, these symptoms disappear and a period of latent syphilis follows that can last for several years and during which people may have no symptoms. Symptoms of tertiary syphilis (or late-stage syphilis) can arise, which include serious damage to many organs such as the heart, brain, spinal cord, and bones.
The risk of syphilis transmission is highest during the first year of infection, which can include primary, secondary, and early latent syphilis. Syphilis can be prevented by practicing safe sex and is treatable at any stage with antibiotics (usually penicillin). Syphilis can also be transmitted at any stage from a pregnant woman to her fetus.
Screening for syphilis is done by blood tests. There are 2 types of blood tests used, usually in a 2-step process, with the second test acting as a confirmatory test if the first test result is positive. These tests look for the presence of antibodies in the blood against syphilis, not the syphilis bacteria.
The USPSTF recommendation applies to nonpregnant adults and adolescents who are at increased risk of syphilis infection and who do not have any symptoms of infection. There is no precise definition of what “increased risk” means because there is much variation among different communities and regions within the United States. In general, people with HIV and men who have sex with men are considered to be at high risk. Syphilis screening in pregnant women is discussed in a separate USPSTF recommendation.
There is convincing evidence that the benefits of early detection and treatment of syphilis are substantial, including curing the infection, preventing transmission to others, and preventing late-stage disease. No studies have directly looked at harms of screening, but they are likely to be small, including false-positive results that lead to further testing, anxiety, and possible stigma. Harms of treatment, such as allergic reactions to penicillin, are also small.
Given the current evidence, the USPSTF has concluded with high certainty that the benefits of screening for syphilis in people who are at increased risk of infection substantially outweigh the potential harms. The optimal frequency for screening is currently not well established.
The USPSTF recommends screening for syphilis in all nonpregnant adults and adolescents at increased risk of infection (called an “A” statement).
National Heart, Lung, and Blood Institutewww.nhlbi.nih.gov/health/health-topics/topics/copd
US Preventive Services Task Forcewww.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement146/syphilis-infection-in-nonpregnant-adults-and-adolescents
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA’s website at www.jama.com. Spanish translations are available in the supplemental content tab. A Patient Page describing the US Preventive Services Task Force was published in the April 26, 2016, issue of JAMA.
Source: US Preventive Services Task Force. Screening for syphilis infection in nonpregnant adults and adolescents: US Preventive Services Task Force recommendation statement. JAMA. doi:10.1001/jama.2016.5824.
Topic: Preventive Medicine
Jin J. Screening for Syphilis. JAMA. 2016;315(21):2367. doi:10.1001/jama.2016.7188
Create a personal account or sign in to: